Pfizer, BioNTech's COVID vaccine candidates fast tracked by FDA

The U.S.-listed shares of the German firm climbed about 10%, while Pfizer’s stock rose about 2% before the bell.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.